This company has been marked as potentially delisted and may not be actively trading. NASDAQ:ZY Zymergen (ZY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Zymergen Stock (NASDAQ:ZY) 30 days 90 days 365 days Advanced Chart Get Zymergen alerts:Sign Up Key Stats Today's Range$2.43▼$2.4350-Day Range$2.35▼$3.1452-Week Range$1.10▼$12.42Volume85 shsAverage Volume1.23 million shsMarket Capitalization$253.58 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc. Read More Receive ZY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Zymergen and its competitors with MarketBeat's FREE daily newsletter. Email Address ZY Stock News HeadlinesThe California crisis in homeowners insurance has only one real solutionMarch 10, 2025 | msn.comHere's how much Sutter Health just spent on its new 12-acre campus in EmeryvilleFebruary 21, 2025 | bizjournals.comTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture. | Porter & Company (Ad)Advanced Materials (AdMs) in Defense Thematic Intelligence Research ReportSeptember 18, 2024 | finance.yahoo.comSEC Charges Zymergen Inc. With Misleading IPO Investors About Company’s Market Potential and Sales ProspectsSeptember 13, 2024 | msn.comOhmium Announces Enakshi Singh as New Chief Financial OfficerAugust 27, 2024 | sg.finance.yahoo.comGinkgo Bioworks Holdings, Inc. (DNA) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comGinkgo Bioworks: Broken NarrativeMay 10, 2024 | seekingalpha.comSee More Headlines ZY Stock Analysis - Frequently Asked Questions When did Zymergen IPO? Zymergen (ZY) raised $401 million in an IPO on Thursday, April 22nd 2021. The company issued 13,600,000 shares at $28.00-$31.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Cowen, UBS Investment Bank and Lazard acted as the underwriters for the IPO. What other stocks do shareholders of Zymergen own? Based on aggregate information from My MarketBeat watchlists, some other companies that Zymergen investors own include Tesla (TSLA), NIO (NIO), Meta Platforms (META), PayPal (PYPL), Snowflake (SNOW) and Teladoc Health (TDOC). Company Calendar Today8/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBasic Materials Industry Commercial physical research Sub-IndustryN/A Current SymbolNASDAQ:ZY CIK1645842 Webwww.zymergen.com Phone415-801-8073FaxN/AEmployees502Year FoundedN/AProfitability EPS (Trailing Twelve Months)($3.55) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$361.79 million Net Margins-2,508.94% Pretax Margin-2,508.42% Return on Equity-93.37% Return on Assets-61.14% Debt Debt-to-Equity RatioN/A Current Ratio4.59 Quick Ratio4.47 Sales & Book Value Annual Sales$16.74 million Price / Sales15.15 Cash FlowN/A Price / Cash FlowN/A Book Value$3.99 per share Price / Book0.61Miscellaneous Outstanding Shares104,355,000Free Float92,145,000Market Cap$253.58 million OptionableNot Optionable Beta1.69 Social Links 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (NASDAQ:ZY) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zymergen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zymergen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
